Cell Therapeutics Inc.

StemCells, Inc. Closes $12.5 Million Equity Financing.
Pediatrics Week; 11/21/2009; 1316 words; ...About StemCells, Inc. StemCells, Inc. is focused on the development...commercialization of cell-based technologies...candidate, HuCNS-SC[R] cells (purified human neural...operations of StemCells, Inc. (the "Company...commercialization of its cell-based technologies...development of ...

Quark Pharmaceuticals to Present Data on its siRNA Therapeutic Programs in Kidney and Lung Diseases.
Gene Therapy Weekly; 11/19/2009; 848 words; ...Pharmaceuticals, Inc., a clinical...RNAi)-based therapeutics, announced that...Developing Targeted Therapeutics track at this year...development of siRNA therapeutics. Quark's strength...of injury delays cell death, allowing...Pharmaceuticals Inc. This article was...

BioMimetic Therapeutics Receives First Orthopedic Marketing Approval for Augment™ Bone Graft.
Blood Weekly; 11/19/2009; 1136 words; BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced that...indications in Canada (see also BioMimetic Therapeutics, Inc.). "After rigorous pre-clinical...proliferation of new bone forming cells and blood vessels, while the b...

New findings reported from J.W. Adams and co-authors describe advances in pharmaceuticals.
Blood Weekly; 11/19/2009; 923 words; ...human embryonic kidney cells stably expressing the...Pharmacology and Experimental Therapeutics (APD791, 3-Methoxy...Pharmacology and Experimental Therapeutics, 2009;331(1...Arena Pharmaceutical Inc., 6166 Nancy Ridge...Pharmacology and Experimental Therapeutics is: American Society...

Zyngenia, Inc. Raises $10 Million in Series a Funding.
Gene Therapy Weekly; 11/19/2009; 1330 words; ...also Zyngenia, Inc.). "Zyngenia...combination therapeutics in a manner...and the B-cell biologics company Cellective Therapeutics into MedImmune...MedImmune Ventures, Inc., as Chief...both Cellective Therapeutics and Human Genome...